Cadherin switching in ovarian cancer progression

The roles of the cadherins in the progression of ovarian cancer to the late stages of the disease state when malignant cells have disseminated within the peritoneal cavity remain poorly understood. In view of these observations, we have undertaken a comprehensive survey of the cadherin subtypes present in normal ovarian surface epithelium and peritoneum and in the tumors and peritoneal effusions of women diagnosed with Stage I or Stage II primary ovarian cancer using a degenerate cloning strategy for sequences highly conserved among this family of cell adhesion molecules. On the basis of the nucleotide sequences of the resultant PCR products, multiple cadherin subtypes (E‐, N‐, P‐cadherin, and cadherin‐4, ‐6, and ‐11) were found to be present in these normal and malignant tissues and cells. P‐cadherin was determined to be the predominant cadherin subtype in normal peritoneum, peritoneal effusions and Stage II tumor masses. An increase in P‐cadherin mRNA and protein expression levels in ovarian tumor masses with progression to later stages of the disease state was confirmed by Northern and Western blot analysis, respectively. In addition, we have determined that the cadherin‐associated protein, known as β‐catenin, is expressed in normal peritoneum, ovarian tumors and malignant cell effusions obtained from women with Stage I or Stage II cancer. Immunoprecipitation studies demonstrated that P‐cadherin was capable of interacting with β‐catenin in these normal and malignant tissues and cells. Collectively, these findings suggest that the regulated expression of P‐cadherin/β‐catenin complexes in ovarian tumor cells may represent a key step in disease progression. © 2003 Wiley‐Liss, Inc.

[1]  G. Christofori,et al.  Cadherins and the tumour progression: is it all in a switch? , 2002, Cancer letters.

[2]  J. Hsieh,et al.  Cell adhesion proteins as tumor suppressors. , 2002, The Journal of urology.

[3]  R. Attanoos,et al.  Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum , 2002, Histopathology.

[4]  J. Thiery,et al.  Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? , 1995, Cell adhesion and communication.

[5]  J. Schalken,et al.  Complex cadherin expression in human prostate cancer cells , 2000, International journal of cancer.

[6]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[7]  M. Sugita,et al.  Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas , 2001, British Journal of Cancer.

[8]  D. Porteous,et al.  BARX2 induces cadherin 6 expression and is a functional suppressor of ovarian cancer progression. , 2001, Cancer research.

[9]  S. Butz,et al.  Distinct cadherin—catenin complexes in Ca2+ dependent cell—cell adhesion , 1994, FEBS letters.

[10]  S. Byers,et al.  Cadherin-11 is expressed in invasive breast cancer cell lines. , 1999, Cancer research.

[11]  J. Palacios,et al.  β-Catenin Expression Pattern in Stage I and II Ovarian Carcinomas : Relationship with β-Catenin Gene Mutations, Clinicopathological Features, and Clinical Outcome , 1999 .

[12]  J. Niloff,et al.  Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H. , 1993, Cancer research.

[13]  M. Takeichi,et al.  The 102 kd cadherin-associated protein: Similarity to vinculin and posttranscriptional regulation of expression , 1991, Cell.

[14]  K. Hamada,et al.  Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. , 2001, Oncology reports.

[15]  O. Blaschuk,et al.  Noncoordinate developmental regulation of N‐cadherin, N‐CAM, integrin, and fibronectin mRNA levels during myoblast terminal differentiation , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.

[16]  Shintaro T. Suzuki Structural and functional diversity of cadherin superfamily: Are new members of cadherin superfamily involved in signal transduction pathway? , 1996, Journal of cellular biochemistry.

[17]  P. Leung,et al.  Ovarian surface epithelium: biology, endocrinology, and pathology. , 2001, Endocrine reviews.

[18]  R. Kemler From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. , 1993, Trends in genetics : TIG.

[19]  H. Tanihara,et al.  Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. , 1991, Cell regulation.

[20]  H. Salazar,et al.  Expression of E-cadherin and N-cadherin in surface epithelial-stromal tumors of the ovary distinguishes mucinous from serous and endometrioid tumors. , 1997, Human pathology.

[21]  J. Nesland,et al.  E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. , 2000, The Journal of pathology.

[22]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[23]  E. Fearon,et al.  Cadherin and catenin alterations in human cancer , 2002, Genes, chromosomes & cancer.

[24]  W. Birchmeier,et al.  Dominant and recessive genes involved in tumor cell invasion. , 1991, Current opinion in cell biology.

[25]  H. Barr,et al.  Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.

[26]  T. Carey,et al.  Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion , 1996, The Journal of cell biology.

[27]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[28]  S. Enerbäck,et al.  E‐cadherin expression in human epithelial ovarian cancer and normal ovary , 1997, International journal of cancer.

[29]  A. P. Soler,et al.  P‐cadherin expression in breast carcinoma indicates poor survival , 1999, Cancer.

[30]  A. P. Soler,et al.  Interaction of alpha-actinin with the cadherin/catenin cell-cell adhesion complex via alpha-catenin , 1995, The Journal of cell biology.

[31]  A. Nose,et al.  Expression and role of E- and P-cadherin adhesion molecules in embryonic histogenesis. II. Skin morphogenesis. , 1989, Development.

[32]  R. Kemler,et al.  Curbing the nuclear activities of β‐catenin , 2000 .

[33]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Fleuren,et al.  Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix. , 1999, The American journal of pathology.

[35]  P. Jensen,et al.  Inhibition of cadherin function differentially affects markers of terminal differentiation in cultured human keratinocytes. , 1999, Journal of cell science.

[36]  W J Nelson,et al.  Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells , 1994, The Journal of cell biology.

[37]  M. Takeichi Morphogenetic roles of classic cadherins. , 1995, Current opinion in cell biology.

[38]  C. Bierkamp,et al.  Cadherins and catenins in development. , 1996, Current opinion in cell biology.

[39]  J. Schalken,et al.  Complex cadherin expression in renal cell carcinoma. , 1996, Cancer research.

[40]  J. Nesland,et al.  E‐cadherin and α‐, β‐, and γ‐catenin protein expression is up‐regulated in ovarian carcinoma cells in serous effusions , 2000 .

[41]  S. Mok,et al.  The biology of ovarian cancer. , 1998, Seminars in oncology.

[42]  J. Schalken,et al.  Cadherin switching in human prostate cancer progression. , 2000, Cancer research.

[43]  L. Chodosh,et al.  Precocious Mammary Gland Development in P-Cadherin–deficient Mice , 1997, The Journal of cell biology.

[44]  Avri Ben-Ze'ev,et al.  The cadherin-catenin adhesion system in signaling and cancer. , 2002, The Journal of clinical investigation.

[45]  W. Nelson,et al.  Differential Regulation of Endogenous Cadherin Expression in Madin-Darby Canine Kidney Cells by Cell-Cell Adhesion and Activation of β-Catenin Signaling* , 2000, The Journal of Biological Chemistry.